Medicamentos y Fármacos Recalls

Pharmaceutical recall notices, chemical impurities, and biological contamination.

Showing 24 of 649 results
PharmaceuticalUSFDA Drugs

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Novo Nordisk Inc.
FDA DrugsClass II

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Presence of Particulate Matter: Hair was found in a prefilled syringe

Jan 7, 2026Novo Nordisk Inc.
PharmaceuticalUSFDA Drugs

traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10

Zydus Pharmaceuticals (USA) Inc
FDA DrugsClass III

traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Jan 7, 2026Zydus Pharmaceuticals (USA) Inc
PharmaceuticalUSFDA Drugs

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

Novo Nordisk Inc.
FDA DrugsClass II

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

Presence of Particulate Matter: Hair was found in a prefilled syringe

Jan 7, 2026Novo Nordisk Inc.
PharmaceuticalUSFDA Drugs

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Glenmark Pharmaceuticals Inc., USA
FDA DrugsClass II

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Jan 7, 2026Glenmark Pharmaceuticals Inc., USA
PharmaceuticalUSFDA Drugs

BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso, TX 79912, NDC 54365-401-29

CareFusion 213, LLC
FDA DrugsClass II

BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso, TX 79912, NDC 54365-401-29

Lack of Assurance of Sterlity

Jan 7, 2026CareFusion 213, LLC
PharmaceuticalAustraliaAustralia

Substitutions approved for shortage of Catapres (clonidine) 150 mcg tablets

TGAAustralia
au-tgaMedicines Safet...

Substitutions approved for shortage of Catapres (clonidine) 150 mcg tablets

The initial Serious Scarcity Substitution Instrument (SSSI) has been extended - refer to new medicine shortage alert: "Extension of substitution approval for shortage of Catapres (clonidine) 150 mcg t...

Dec 21, 2025TGA
PharmaceuticalUKUK

MHRA Safety Roundup: December 2025

MHRAUK
uk-mhraMedicines Recall

MHRA Safety Roundup: December 2025

Summary of the latest safety advice for medicines and medical device users...

Dec 18, 2025MHRA
PharmaceuticalAustraliaAustralia

Shortage of Creon (pancreatic extract) capsules extended

TGAAustralia
au-tgaMedicines Safet...

Shortage of Creon (pancreatic extract) capsules extended

Supply constraints will apply to Creon 25,000 unit and 35,000 unit capsules until 30 June 2026....

Dec 16, 2025TGA
PharmaceuticalUKUK

Class 3 Medicines Recall: Activase Pharmaceuticals Limited, Prednisolone 5mg Soluble Tablets, EL(25)A/54

Activase Pharmaceuticals LimitedUK
uk-mhraMedicines Recall

Class 3 Medicines Recall: Activase Pharmaceuticals Limited, Prednisolone 5mg Soluble Tablets, EL(25)A/54

Activase Pharmaceuticals Limited is recalling two batches of Prednisolone 5mg Soluble Tablets as a precautionary measure due to a limited number of reports of blister pockets becoming swollen over tim...

Dec 15, 2025Activase Pharmaceuticals Limited
PharmaceuticalUKUK

Class 2 Medicines Recall: Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion, EL(25)A/53

Hameln Pharma LtdUK
uk-mhraMedicines Recall

Class 2 Medicines Recall: Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion, EL(25)A/53

Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion....

Dec 11, 2025Hameln Pharma Ltd
PharmaceuticalUKUK

Class 4 Medicines Defect Notification: Flamingo Pharma UK Ltd, Amitriptyline Hydrochloride 10mg, 25mg, 50mg Tablets, EL(25)A/52

Flamingo Pharma UK LtdUK
uk-mhraMedicines Recall

Class 4 Medicines Defect Notification: Flamingo Pharma UK Ltd, Amitriptyline Hydrochloride 10mg, 25mg, 50mg Tablets, EL(25)A/52

Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information....

Dec 10, 2025Flamingo Pharma UK Ltd
PharmaceuticalAustraliaAustralia

Brahmi Vati tablets (Ayurvedic medicine)

TGAAustralia
au-tgaMedicines Safet...

Brahmi Vati tablets (Ayurvedic medicine)

Brahmi Vati tablets pose a serious risk to your health and should not be taken....

Dec 9, 2025TGA
PharmaceuticalAustraliaAustralia

Manasamitra Vadakam tablets (Ayurvedic medicine)

TGAAustralia
au-tgaMedicines Safet...

Manasamitra Vadakam tablets (Ayurvedic medicine)

Manasamitra Vakakam tablets pose a serious risk to your health and should not be taken....

Dec 9, 2025TGA
PharmaceuticalAustraliaAustralia

Kumar Kalyan Rasa tablets (Ayurvedic medicine)

TGAAustralia
au-tgaMedicines Safet...

Kumar Kalyan Rasa tablets (Ayurvedic medicine)

Kumar Kalyan Rasa tablets pose a serious risk to your health and should not be taken....

Dec 9, 2025TGA
PharmaceuticalAustraliaAustralia

Product warnings updated for GLP-1 RA class

TGAAustralia
au-tgaMedicines Safet...

Product warnings updated for GLP-1 RA class

We have updated the product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues. This relatively new and high-profile class of medicines is used to treat type 2 diab...

Nov 30, 2025TGA
PharmaceuticalUKUK

MHRA Safety Roundup: November 2025

MHRAUK
uk-mhraMedicines Recall

MHRA Safety Roundup: November 2025

Summary of the latest safety advice for medicines and medical device users...

Nov 27, 2025MHRA
PharmaceuticalUKUK

Class 4 Medicines Defect Notification: Special Concept Development UK Limited, Baclofen 10mg Tablets, EL(25)A/51

Special Concept Development UK LimitedUK
uk-mhraMedicines Recall

Class 4 Medicines Defect Notification: Special Concept Development UK Limited, Baclofen 10mg Tablets, EL(25)A/51

Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information....

Nov 27, 2025Special Concept Development UK Limited
PharmaceuticalUKUK

Class 4 Medicines Defect Notification: Lexon UK Ltd, Moclobemide 150mg tablets, EL(25)A/50

Lexon UK LtdUK
uk-mhraMedicines Recall

Class 4 Medicines Defect Notification: Lexon UK Ltd, Moclobemide 150mg tablets, EL(25)A/50

Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information....

Nov 25, 2025Lexon UK Ltd
PharmaceuticalUKUK

Class 3 Medicines Recall: Sun Pharmaceutical Industries Limited, Fingolimod SUN 0.5mg hard capsules, EL(25)A/49

Sun Pharmaceutical Industries LimitedUK
uk-mhraMedicines Recall

Class 3 Medicines Recall: Sun Pharmaceutical Industries Limited, Fingolimod SUN 0.5mg hard capsules, EL(25)A/49

Sun Pharma UK Limited is conducting a precautionary recall of a single batch of Fingolimod SUN 0.5 mg hard capsules due to reports of capsule breakage on removing from the blister. No other batches of...

Nov 20, 2025Sun Pharmaceutical Industries Limited
PharmaceuticalUKUK

Class 3 Medicines Recall: Sun Pharmaceutical Industries Limited, Atorvastatin 20mg and 80mg Film-coated Tablets, EL(25)A/48

Sun Pharmaceutical Industries LimitedUK
uk-mhraMedicines Recall

Class 3 Medicines Recall: Sun Pharmaceutical Industries Limited, Atorvastatin 20mg and 80mg Film-coated Tablets, EL(25)A/48

Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies....

Nov 11, 2025Sun Pharmaceutical Industries Limited
PharmaceuticalUKUK

Class 3 Medicines Recall: Zambon SpA, Emylif 50mg orodispersible film, EL(25)A/47

Zambon SpAUK
uk-mhraMedicines Recall

Class 3 Medicines Recall: Zambon SpA, Emylif 50mg orodispersible film, EL(25)A/47

Zambon SpA is recalling an affected batch as a precautionary measure due to out of specification results for unknown impurities during ongoing stability testing....

Nov 10, 2025Zambon SpA
PharmaceuticalUKUK

MHRA Safety Roundup: October 2025

MHRAUK
uk-mhraMedicines Recall

MHRA Safety Roundup: October 2025

Summary of the latest safety advice for medicines and medical device users...

Oct 28, 2025MHRA
PharmaceuticalUKUK

Class 2 Medicines Recall: Baxter Healthcare Limited, Compound Sodium Lactate Solution for Infusion BP (Hartmann's Solution for infusion) in Viaflo 1000ml, EL(25)A/46

Baxter Healthcare LimitedUK
uk-mhraMedicines Recall

Class 2 Medicines Recall: Baxter Healthcare Limited, Compound Sodium Lactate Solution for Infusion BP (Hartmann's Solution for infusion) in Viaflo 1000ml, EL(25)A/46

Baxter Healthcare is recalling one batch of Compound Sodium Lactate (Hartmann’s Solution) 1000mL. This is due to a packaging error where some cartons labelled as Hartmann’s Solution may contain Ringer...

Oct 28, 2025Baxter Healthcare Limited
PharmaceuticalUKUK

Class 4 Medicines Defect Notification: Relonchem Ltd, Various Products, EL(25)A/44

Relonchem LtdUK
uk-mhraMedicines Recall

Class 4 Medicines Defect Notification: Relonchem Ltd, Various Products, EL(25)A/44

Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigne...

Oct 23, 2025Relonchem Ltd

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.